McKinsey argues that the biggest challenge for humanoid robots is no longer AI capability; it’s the hardware supply chain. Humanoid robots depend on a complex hardware stack. The most expensive and critical area is actuation (motors, gears, movement systems), representing roughly 40–60% of total cost. Robot hands are especially difficult and dependent on this complexity.

What follows from these facts? This is an area China dominates, and it follows humanoid robotics, too.

As China has done for the EVs, the typical/average global humanoid robot of the 2030s-40s will be Chinese-made, ≈ $10k, and sold in the global south.

McKinsey - Turning humanoid supply chain constraints into billion-dollar wins

1 comment

sorted by: hot top controversial new old
[–] 2 points 6 months ago

McKinsey is trash.

  • source
  • 5 comments in c/hackernews@lemmy.bestiver.se view that post
    [–] 4 points 6 months ago (1 child)

    o1 ? That's from almost 2 years ago when reasoning was new.

  • source
  • hideshow 1 child comment
  • [–] 4 points 6 months ago (2 children)

    So 33% would be misdiagnosed and die. Cool.

  • source
  • hideshow 2 child comments
  • [–] 1 point 6 months ago*

    Not necessarily and this is something the article doesn't even bring up. While people are triaged before seeing the ER doc, the ER doc's job itself is to triage and determine whether the patient needs to be further worked up in the hospital or outpatient. Often times an ER doc may not have a clue about the diagnosis but the critical thing to be correct about is if the patient needs to stay to get worked up. They give an example about docs who think a clot is due to an anticoagulant when the AI thought it might be due to lupus. The ER doc's concern is that the patient be observed/admitted and the internal medicine team would likely make that catch (or the rheumatologist).

  • source
  • parent